Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sm-TSP-2 vaccine for intestinal schistosomiasis
NCT03910972Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Oct 2019
- Primary completion
- Nov 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Sm-TSP-2/Alhydrogel in schistosomiasis, sponsored by Baylor College of Medicine. Started Oct 2019; status: completed.
02
Drugs
Sm-TSP-2/Alhydrogel
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT03910972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910972.